Collegium Pharmaceutical
COLL
COLL
133 hedge funds and large institutions have $739M invested in Collegium Pharmaceutical in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
48% less call options, than puts
Call options by funds: $1.27M | Put options by funds: $2.46M
Holders
133
Holding in Top 10
3
Calls
$1.27M
Puts
$2.46M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$7.93M | |
| 3 | +$6.49M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.57M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$5.52M |
Top Sellers
| 1 | -$7.59M | |
| 2 | -$6.44M | |
| 3 | -$3.8M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.68M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$3.61M |